Lv4
452 积分 2023-07-26 加入
Role of Adjuvant Therapy in Esophageal Cancer Patients After Neoadjuvant Therapy and Esophagectomy
5天前
已关闭
Development of a Chinese version of the Modified Barthel Index — validity and reliability
10天前
已完结
Adjuvant immunotherapy versus observation in patients with lymph node-positive status after neoadjuvant chemotherapy for esophageal squamous cell carcinoma: a prospective, single-center, controlled phase II study
14天前
已关闭
Real-world Evaluation of the Efficacy of Neoadjuvant DCF Over CF in Esophageal Squamous Cell Carcinoma: Propensity Score-matched Analysis From 85 Authorized Institutes for Esophageal Cancer in Japan
14天前
已完结
Comparing the Efficacy and Safety of IC-ICCRT-IO With CT-CCRT for Unresectable Locally Advanced ESCC: A Retrospective Analysis
21天前
已完结
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
2个月前
已完结
Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration
2个月前
已完结
Consensus statement on ctDNA minimal residual disease (MRD) testing in early-stage NSCLC – A Delphi study by the Asian Thoracic Oncology Research Group (ATORG)
2个月前
已关闭
Effective Combinations of Radiotherapy and Immunotherapy in the Treatment of Esophageal Squamous Cell Carcinoma
3个月前
已完结
皖公网安备34019202002308
